Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Jun 17, 2016
Insider Transaction Report
Form 4
MCCABE JOHN J
Senior Vice President, Finance
Transactions
- Award
Stock Option (Right to Buy)
2016-06-15+6,672→ 6,672 totalExercise: $0.28From: 2016-06-15Exp: 2026-02-24→ Common Stock (6,672 underlying)
Footnotes (1)
- [F1]On February 25, 2016, the reporting person was granted an option to purchase 20,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 6,672 shares.